Table 1.
Baseline characteristics of subjects.
| CHARACTERISTICS | SURVIVORS | ALL-CAUSE DEATH | CANCER DEATH |
|---|---|---|---|
| n (%) | 1,600 (83.3) | 258 (13.4) | 87 (4.5) |
| Age (ys) | 61.0 ± 10.3 | 73.1 ± 9.3 | 70.5 ± 9.5 |
| Sex (% male) | 794 (41.4) | 153 (59.3) | 52 (59.8) |
| Body mass index (kg/m2) | 23.2 ± 3.0 | 22.4 ± 3.4 | 23.3 ± 3.4 |
| Systolic blood pressure (mmHg) | 139.0 ± 21.3 | 147.2 ± 23.8 | 146.1 ± 21.8 |
| Diastolic blood pressure (mmHg) | 81.9 ± 12.1 | 82.5 ± 12.3 | 84.3 ± 12.4 |
| Hypertensive medication (% yes) | 292 (18.3) | 74 (28.7) | 23 (26.4) |
| Total cholesterol (mg/dl) | 200.6 ± 34.4 | 197.4 ± 35.5 | 193.7 ± 33.8 |
| HDL cholesterol (mg/dl) | 55.9 ± 14.0 | 54.5 ± 14.1 | 54.3 ± 14.3 |
| Triglycerides (mg/dl)* | 98.6 | 98.3 | 92.9 |
| Range | 28–1284 | 36–843 | 38–843 |
| Hyperlipidemic medication (% yes) | 73 (4.6) | 16 (6.2) | 5 (5.7) |
| Fasting plasma glucose (mg/dl) | 97.4 ± 18.8 | 98.9 ± 22.4 | 98.9 ± 21.9 |
| HbA1c (%) | 5.2 ± 0.7 | 5.7 ± 1.1 | 5.7 ± 1.4 |
| Diabetic medication (%) | 44 (2.8) | 14 (5.4) | 5 (5.7) |
| eGFR (ml/min/1.73 m2) | 62.9 ± 16.4 | 62.5 ± 17.2 | 63.9 ± 17.7 |
| Uric acid (mg/dl) | 4.9 ± 1.4 | 5.1 ± 1.5 | 5.1 ± 1.7 |
| Alcohol intake (% yes) | 350 (21.9) | 63 (24.4) | 25 (28.7) |
| Current smoking (% yes) | 247 (15.4) | 69 (26.7) | 21 (24.1) |
| Infammatory and hemostatic markers | |||
| CRP (mg/dl) | 0.18 | 0.21 | 0.22 |
| Range | 0.1–11.5 | 0.1–5.2 | 0.1–2.7 |
| High-sensitive CRP (mg/dl) | 0.039 | 0.07 | 0.07 |
| Range | 0.002–11.500 | 0.002–40.000 | 0.164–1.227 |
| Fibrinogen (g/l) | 312.2 ± 61.9 | 331.7 ± 70.1 | 315.4 ± 64.3 |
| von Willebrand factor (%) | 142.1 ± 41.7 | 164.8 ± 33.2 | 145.1 ± 41.3 |
| Plasminogen activator-1 | 27.8 ± 20.7 | 32.6 ± 29.4 | 28.6 ± 22.3 |
| Tissue factor | 234.3 ± 57.1 | 259.5 ± 48.2 | 237.6 ± 56.9 |
Notes: Data are mean ± standard deviation, geometric mean, range, or percent.
*
These variables were represented as original scale after analysis by log (natural) transformed values.
Abbreviations: eGFR, estimated glomerular filtration rate; CRP, C-reactive protein.